U.S. Markets close in 2 hrs 20 mins

Why Verve Therapeutics Is Up More Than 16% This Week

·3 min read
Why Verve Therapeutics Is Up More Than 16% This Week
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Verve Therapeutics (NASDAQ: VERV) is up 16.5% for the week. The biotech stock, which was as low as $41.52 a share on Monday, climbed as high as $48.39 by Thursday. Investors closely watch Cathie Wood's ARK Genomic Revolution ETF fund.